Assignee
METABOLEX INC
US·31 granted patents·26 pending applications·465 citations·filing 1995–2013
Top patents by PatentIndex Score
57 records- 0196US7638541B25-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidineMETABOLEX INC·Filed 2007·Granted Dec 29, 2009·43 cites·2 claims
- 0295US6613802B1Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemiaMETABOLEX INC·Filed 2000·Granted Sep 2, 2003·98 cites·6 claims
- 0393US8476308B2GPR120 receptor agonists and uses thereofMETABOLEX INC·Filed 2012·Granted Jul 2, 2013·12 cites·6 claims
- 0493US7432394B2Resolution of α-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylaminesMETABOLEX INC·Filed 2006·Granted Oct 7, 2008·12 cites·21 claims
- 0591US6646004B1Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemiaMETABOLEX INC·Filed 2000·Granted Nov 11, 2003·40 cites·17 claims
- 0690US7714131B2Process for the stereoselective preparation of (−)-halofenate and derivatives thereofMETABOLEX INC·Filed 2006·Granted May 11, 2010·9 cites·16 claims
- 0789US6624194B1Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemiaMETABOLEX INC·Filed 2000·Granted Sep 23, 2003·38 cites·17 claims
- 0888US7199259B2Resolution of α-(phenoxy)phenylacetic acid derivativesMETABOLEX INC·Filed 2003·Granted Apr 3, 2007·16 cites·18 claims
- 0987US7053180B2Isolated islet beta-cell two-pore domain potassium channelMETABOLEX INC·Filed 2003·Granted May 30, 2006·15 cites·1 claims
- 1086US6020200AEncapsulation compositions and methodsMETABOLEX INC·Filed 1996·Granted Feb 1, 2000·60 cites·3 claims
- 1184US8598374B2GPR120 receptor agonists and uses thereofMETABOLEX INC·Filed 2012·Granted Dec 3, 2013·6 cites·9 claims
- 1282US7323480B2Substituted triazoles as modulators of PPAR and methods of their preparationMETABOLEX INC·Filed 2005·Granted Jan 29, 2008·6 cites·21 claims
- 1381US7087394B2Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-TRPMETABOLEX INC·Filed 2004·Granted Aug 8, 2006·18 cites·9 claims
- 1480US7576131B2Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemiaMETABOLEX INC·Filed 2003·Granted Aug 18, 2009·12 cites·21 claims
- 1579US7622491B2Modulators of PPAR and methods of their preparationMETABOLEX INC·Filed 2005·Granted Nov 24, 2009·4 cites·57 claims
- 1679US7371888B2α-(Trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agentsMETABOLEX INC·Filed 2005·Granted May 13, 2008·3 cites·10 claims
- 1779US7344844B2Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)METABOLEX INC·Filed 2006·Granted Mar 18, 2008·1 cites·7 claims
- 1877US7405289B2Pancreatic islet transcription factor and uses thereofMETABOLEX INC·Filed 2003·Granted Jul 29, 2008·4 cites·16 claims
- 1976US7144985B2Methods and reagents for diagnosis and treatment of diabetesMETABOLEX INC·Filed 2002·Granted Dec 5, 2006·3 cites·10 claims
- 2072US7642358B2Substituted phenylacetic acidsMETABOLEX INC·Filed 2006·Granted Jan 5, 2010·1 cites·24 claims
- 2170US7510851B2Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemiaMETABOLEX INC·Filed 2002·Granted Mar 31, 2009·5 cites·20 claims
- 2270US7078421B2Substituted phenylacetic acidsMETABOLEX INC·Filed 2003·Granted Jul 18, 2006·4 cites·31 claims
- 2369US8354448B2Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetesMETABOLEX INC·Filed 2009·Granted Jan 15, 2013·0 cites·14 claims
- 2469US7109021B2Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)METABOLEX INC·Filed 2004·Granted Sep 19, 2006·1 cites·5 claims
- 2568USRE40624ECompositions and methods of using apoptosis signaling kinase related kinase (ASKRK)METABOLEX INC·Filed 2007·Granted Jan 20, 2009·0 cites·5 claims
- 2667US5916790AEncapsulation compositions, and methodsMETABOLEX INC·Filed 1995·Granted Jun 29, 1999·25 cites·39 claims
- 2765US2008318312A1Pancreatic islet transcription factor and uses thereofMETABOLEX INC·Filed 2008·Application pending·0 cites
- 2863US7556930B2CD39L3 and its role in diabetesMETABOLEX INC·Filed 2006·Granted Jul 7, 2009·2 cites·6 claims
- 2963US2010152295A1Methods of reducing small, dense ldl particlesMETABOLEX INC·Filed 2009·Application pending·0 cites
- 3062US7294698B2Methods and reagents for diagnosis and treatment of diabetesMETABOLEX INC·Filed 2006·Granted Nov 13, 2007·0 cites·1 claims
- 3162US2007270490A1Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemiaMETABOLEX INC·Filed 2007·Application pending·0 cites
- 3261US2014128439A1Methods for Treating Gout FlaresMETABOLEX INC·Filed 2013·Application pending·0 cites
- 3360US5738876AMethod of solution overcoating with gelling polymerMETABOLEX INC·Filed 1996·Granted Apr 14, 1998·27 cites·15 claims
- 3460US2008248010A1Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)METABOLEX INC·Filed 2008·Application pending·0 cites
- 3559US2010087468A1Modulators of ppar and methods of their preparationMETABOLEX INC·Filed 2009·Application pending·0 cites
- 3658US2009093650A1Resolution of alpha-(phenoxy)phenylacetic acid derivatives with naphthyl-alkylaminesMETABOLEX INC·Filed 2008·Application pending·0 cites
- 3757US8912356B2DCC mediated coupling for halofenate manufactureMETABOLEX INC·Filed 2013·Granted Dec 16, 2014·0 cites·20 claims
- 3857US2008287441A1Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agentsMETABOLEX INC·Filed 2008·Application pending·0 cites
- 3956US7491533B2Polynucleotides encoding an isolated β-islet cell two-pore domain potassium channelMETABOLEX INC·Filed 2006·Granted Feb 17, 2009·0 cites·5 claims
- 4056US2014121246A1Gpr120 receptor agonists and uses thereofMETABOLEX INC·Filed 2013·Application pending·0 cites
- 4156US2005075396A1Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes and hyperlipidemiaMETABOLEX INC·Filed 2003·Application pending·0 cites
- 4254US2008108630A1Substituted triazoles as modulators of ppar and methods of their preparationMETABOLEX INC·Filed 2007·Application pending·0 cites
- 4354US2007203243A1Resolution of alpha-(phenoxy) phenylacetic acid derivativesMETABOLEX INC·Filed 2007·Application pending·0 cites
- 4452US2010216827A1Aryl gpr120 receptor agonists and uses thereofMETABOLEX INC·Filed 2009·Application pending·0 cites
- 4551US2009270404A1Oxymethylene aryl compounds and uses thereofMETABOLEX INC·Filed 2009·Application pending·0 cites
- 4651US2007031897A1Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-TRPMETABOLEX INC·Filed 2006·Application pending·0 cites
- 4749US2004002114A1Nucleic acids encoding a G-protein coupled receptor involved in islet cell signalingMETABOLEX INC·Filed 2003·Application pending·0 cites
- 4849US2008064857A1Methods and Reagents for Diagnosis and Treatment of DiabetesMETABOLEX INC·Filed 2007·Application pending·0 cites
- 4947US2005208516A1Methods and reagents for diagnosis and treatment of diabetesMETABOLEX INC·Filed 2004·Application pending·0 cites
- 5044US2006074018A1Methods of diagnosing & treating diabetes and insulin resistanceMETABOLEX INC·Filed 2003·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →